section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: thromboembolic events, peripheral ischemia, tachycardia

Endo: hyperglycemia

Hemat: thrombocytopenia

Neuro: delirium

Misc: fungal infection

Interactions

Drug-drug:

Availability

Route/Dosage

US Brand Names

Giapreza

Action

  • Causes vasoconstriction and release of aldosterone, which lead to an increase in blood pressure.
Therapeutic effects:
  • Increase in mean arterial pressure.

Classifications

Therapeutic Classification: vasopressors

Pharmacologic Classification: vasopressors

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Metabolized by aminopeptidase A and angiotensin converting enzyme 2 to angiotensin-(2-8) [angiotensin III] and angiotensin-(1-7), respectively in plasma, erythrocytes and many major organs.

Half-Life: <1 min.

Time/Action Profile

(increase in mean arterial pressure)

ROUTEONSETPEAKDURATION
IVminutes5 minminutes



Patient/Family Teaching

Pronunciation

an-jee-oh-TEN-sin too